History of Bipolar Disorder
The understanding and treatment of bipolar disorder have evolved dramatically over centuries. From the early observations of mood disturbances by Hippocrates to the sophisticated treatments available today, the journey has been marked by significant milestones and breakthroughs.
As we delve into this historical timeline, we will explore how early medical theories, pivotal research studies, and groundbreaking therapeutic approaches have shaped our current understanding of bipolar disorder.
This evolution underscores the importance of continuous research and innovation in improving the lives of those affected by this condition.
460-370 BCE
Hippocrates
the ancient Greek physician, identifies "melancholia" and "mania" as distinct states of mood disturbances, laying the groundwork for future understanding of mood disorders.
2nd Century CE
Aretaeus of Cappadocia
Aretaeus of Cappadocia, a Greek physician, describes the link between melancholia and mania, suggesting they are different phases of the same illness. This early conceptualization hints at what is now known as bipolar disorder.
19th Century
1854
Jean-Pierre Falret
French psychiatrist Jean-Pierre Falret describes "folie circulaire" (circular insanity), characterized by alternating episodes of depression and mania. This is one of the first documented descriptions of bipolar disorder.
1875
Jules Baillarger
Baillarger, a French psychiatrist, independently describes "folie à double forme," similar to Falret's circular insanity, reinforcing the concept of bipolarity.
1899
Emil Kraepelin
German psychiatrist Emil Kraepelin differentiates manic-depressive illness from schizophrenia in his classification of mental disorders. Kraepelin's work is pivotal in the modern understanding of bipolar disorder as a distinct condition.
Early 20th Century
1949
John Cade
Australian psychiatrist John Cade discovers the mood-stabilizing effects of lithium salts, marking a significant breakthrough in the treatment of bipolar disorder. Lithium becomes the first effective pharmacological treatment for the condition.
1952
Electroconvulsive Therapy (ECT)
ECT begins to be used more widely as a treatment for severe manic and depressive episodes in bipolar disorder, showing efficacy in cases resistant to medication.
1957
Chlorpromazine
The antipsychotic medication chlorpromazine is introduced, helping manage manic episodes in bipolar disorder.
Late 20th Century
1960s
Tricyclic Antidepressants (TCAs)
TCAs like imipramine are used to treat depressive episodes in bipolar disorder, though concerns about triggering mania arise.
1970s
FDA Approval of Lithium
The U.S. Food and Drug Administration (FDA) approves lithium for the treatment of mania, recognizing its significant role in managing bipolar disorder.
1970s
Cognitive Behavioral Therapy (CBT) and Psychotherapy
CBT and other forms of psychotherapy begin to be used as adjunct treatments for bipolar disorder, focusing on helping patients manage symptoms, identify triggers, and develop coping strategies.
1980
DSM-III Publication
The American Psychiatric Association's DSM-III (Diagnostic and Statistical Manual of Mental Disorders, third edition) formally includes bipolar disorder as a distinct category, distinguishing it from unipolar depression.
1987
Selective Serotonin Reuptake Inhibitors (SSRIs)
SSRIs, starting with fluoxetine, become popular for treating depressive episodes in bipolar disorder, though careful monitoring is required to avoid triggering mania.
1994
DSM-IV Publication
The DSM-IV introduces more specific criteria for diagnosing bipolar disorder, including the distinction between Bipolar I and Bipolar II disorders.
21st Century
2000
Atypical Antipsychotics
Medications such as olanzapine and risperidone begin to be used for treating bipolar disorder, offering new options with different side effect profiles compared to traditional antipsychotics.
2002
FDA Approval of Lamotrigine
Lamotrigine, an anticonvulsant, is approved by the FDA for the maintenance treatment of bipolar disorder, particularly for preventing depressive episodes.
2005
Transcranial Magnetic Stimulation (TMS)
TMS is explored as a treatment option for bipolar depression, providing a non-invasive alternative for patients resistant to medication.
2010
Ketogenic Diet Research
Emerging studies suggest the ketogenic diet, high in fats and low in carbohydrates, may have mood-stabilizing effects for some individuals with bipolar disorder.
2013
DSM-5 Publication
The DSM-5 further refines the criteria for diagnosing bipolar disorder, emphasizing the importance of recognizing mixed features and rapid cycling in the disorder's presentation.
2015
Research on Psychedelics
Preliminary research into the use of psychedelics, such as psilocybin and ketamine, indicates potential benefits for treatment-resistant depression and bipolar disorder, prompting further studies.
2019
Advances in Genetic Research
Large-scale genetic studies identify several genetic variants associated with bipolar disorder, enhancing the understanding of its biological underpinnings and opening avenues for personalized medicine.
2020
Digital Health Tools
Mobile apps and digital health tools begin to be integrated into the management of bipolar disorder, offering new ways to monitor symptoms, medication adherence, and provide psychoeducation.
2021
Expanded Use of Psychedelics in Clinical Trials
Clinical trials on psychedelics, including MDMA and LSD, gain momentum, investigating their efficacy in treating mood disorders, including bipolar disorder.
2022
Research on Gut-Brain Axis
Emerging research explores the role of the gut-brain axis in bipolar disorder, suggesting that gut microbiota may influence mood and cognitive functions, offering potential new targets for treatment.
2023
Advances in Neuroimaging Techniques
Development of more sophisticated neuroimaging techniques enhances the understanding of brain structure and function in bipolar disorder, contributing to more accurate diagnoses and targeted treatments.
right now
Personalized Medicine and Biomarkers
Ongoing research continues to focus on personalized medicine approaches, aiming to tailor treatments based on individual genetic profiles and biomarkers to improve efficacy and reduce side effects.
Coming soon
FDA Approval of Novel Therapies
New medications and therapies, including those targeting the gut-brain axis and utilizing advanced neurostimulation techniques, are expected to receive FDA approval, offering more options for individuals with bipolar disorder.
The #1 online clinic specializing in bipolar
Access to our clinicians,
even between sessions.
How it works
Getting care at Sway is simple
1
Book Your First Appointment
Schedule a time that works for you with one of our expert clinicians.
2
Create Your Plan Together
Collaborate with your clinician to develop a tailored treatment plan.
3
Start Your Journey
Track progress, adjust as needed, and thrive with ongoing support.
How is Sway different?
Built for bipolar from the ground up. Not just adapted from general psychiatry.
Traditional Care
just enough time for side effects.
guesswork and memory.
Sway Health
symptom scores and sleep data.
Telehealth allows for care from
the comfort of your home.
Ready to experience truly specialized care?
Frequently Asked Questions
Answered before you ask!
What is Sway Health?
Sway Health is a specialized telehealth platform that provides Integrative Care for individuals with bipolar disorder. Our approach combines psychiatry, personalized psychoeducation, peer support and out-of-session access to your clinician to help manage mood symptoms and improve daily functioning.
What is Integrated Care?
Integrative care brings together all the latest evidence-based treatments and modalities for bipolar disorder under one roof. We also fully integrate the work of your provider team: if you have a psychotherapist and PCP we will provide them with full treatment updates with your permission.
Who will be treating me?
Our care is provided by psychiatrists and psychiatric nurse practitioners. They are all equipped to provide you with integrated care.
Who are the people behind Sway?
Constant Care allows you to stay connected with your clinician between scheduled sessions.
Through our secure messaging system, you can ask questions, share updates, or discuss any concerns you may have.
This ensures that your care is continuous and that you have support whenever needed, even outside of regular appointment times. This is included in your treatment plan at no additional cost.
How does Sway's specialized care work?
Bipolar disorder is a complex condition and each patient needs to become an expert on their own case. Psychoeducation teaches how to recognize patterns, triggers and early warning signs and adopt strategies to manage symptoms.
There is a lot of evidence basis that timely psychoeducation is crucial in improving adherence, reducing relapses and overall improve quality of life.
Take a look at our Resources
Become an expert in Bipolar Disorder and take ownership of your care
Begin your journey
We’ll ask some basic questions to see if we’re a good fit for you.
Then, we’ll match you with a clinician so that you can self-schedule an appointment.